Literature DB >> 24172864

Characterization of a Brg1 hypomorphic allele demonstrates that genetic and biochemical activity are tightly correlated.

Ronald L Chandler1, Ying Zhang1, Terry Magnuson1, Scott J Bultman1.   

Abstract

Mammalian SWI/SNF-related complexes are recruited to the promoters of numerous target genes, and the BRG1 catalytic subunit confers ATPase activity necessary to slide or evict nucleosomes and to regulate transcription. Based on gene-targeting experiments in mice, BRG1 is essential for early embryonic development. However, Brg1 null mutants have provided limited insight into gene-dosage considerations and structure-function relationships. To extend our knowledge of BRG1 function, we describe the genetic and biochemical characteristics of an ENU-induced hypomorphic mutation that encodes a protein with a single amino-acid substitution (E1083G) within the bilobal ATPase/chromatin-remodeling domain. Brg1(ENU1/ENU1) mice have ~50% genetic activity and survive embryogenesis but exhibit a postnatal developmental phenotype associated with runting and incompletely penetrant lethality. The E1083G mutant protein is stable, and experiments with recombinant FLAG-tagged BRG1 proteins demonstrated that it retains full ATPase activity. Yet the biochemical activity of the mutant protein is diminished to ~50% of normal in chromatin-remodeling assays. Consistent with these findings, the E1083G substitution is predicted to disrupt a structurally conserved α-helix within the lobe that participates in DNA translocation but does not contain the ATPase catalytic site. We propose that this α-helix participates in the DNA translocation cycle by mechanistically linking DNA interaction surfaces at the DNA entry/anchor point to those within the Helicase C domain of lobe 2 of the bilobal ATPase motor. Taken together, these results demonstrate that BRG1 genetic and biochemical activities are tightly correlated. They also indicate that BRG1 ATPase activity is necessary but not sufficient for chromatin remodeling.

Entities:  

Keywords:  ATPase; BRG1 E1083G; chromatin remodeling; hypomorph; runting

Mesh:

Substances:

Year:  2013        PMID: 24172864      PMCID: PMC3962535          DOI: 10.4161/epi.26879

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  37 in total

1.  X-ray structures of the Sulfolobus solfataricus SWI2/SNF2 ATPase core and its complex with DNA.

Authors:  Harald Dürr; Christian Körner; Marisa Müller; Volker Hickmann; Karl-Peter Hopfner
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

2.  COBALT: constraint-based alignment tool for multiple protein sequences.

Authors:  Jason S Papadopoulos; Richa Agarwala
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Maternal BRG1 regulates zygotic genome activation in the mouse.

Authors:  Scott J Bultman; Thomas C Gebuhr; Hua Pan; Petr Svoboda; Richard M Schultz; Terry Magnuson
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

5.  A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development.

Authors:  Scott J Bultman; Thomas C Gebuhr; Terry Magnuson
Journal:  Genes Dev       Date:  2005-11-14       Impact factor: 11.361

6.  A conserved Swi2/Snf2 ATPase motif couples ATP hydrolysis to chromatin remodeling.

Authors:  Corey L Smith; Craig L Peterson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  BRG1 requirement for long-range interaction of a locus control region with a downstream promoter.

Authors:  Shin-Il Kim; Scott J Bultman; Christine M Kiefer; Ann Dean; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

8.  Characterization of mammary tumors from Brg1 heterozygous mice.

Authors:  S J Bultman; J I Herschkowitz; V Godfrey; T C Gebuhr; M Yaniv; C M Perou; T Magnuson
Journal:  Oncogene       Date:  2007-07-16       Impact factor: 9.867

9.  The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.

Authors:  Kevin W Trotter; Hua-Ying Fan; Melissa L Ivey; Robert E Kingston; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

10.  BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription.

Authors:  Shin-Il Kim; Emery H Bresnick; Scott J Bultman
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.